Ariadne Australia Limited (ARA.AX)
AUD 0.54
(1.89%)
AUD 0.54
(1.89%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -922 Thousand | 10.6 Million | -1.19 Million | 3.5 Million | 7.11 Million | 21.3 Million |
| Net Income | 1.57 Million | 11.07 Million | -6.59 Million | 10.57 Million | -7.14 Million | -2.91 Million |
| Depreciation & Amortization | 401 Thousand | 410 Thousand | 463 Thousand | 586 Thousand | 8.19 Million | 242 Thousand |
| Deferred income taxes | - | -2.01 Million | -1.93 Million | -1.87 Million | -17.11 Million | -363 Thousand |
| Stock-based compensation | 125 Thousand | 84 Thousand | 13 Thousand | 4000.00 | 35 Thousand | 60 Thousand |
| Change in working capital | -2.54 Million | -1.13 Million | -956 Thousand | -752 Thousand | -577 Thousand | 303 Thousand |
| Other non-cash items | -476 Thousand | 2.18 Million | 7.81 Million | -5.03 Million | 23.7 Million | 23.97 Million |
| Investing Cash Flow | -8.55 Million | 10.97 Million | 4.95 Million | -14.38 Million | -3.1 Million | 6.38 Million |
| Investments in PPE | 581 Thousand | -1.1 Million | -2000.00 | -5000.00 | -4000.00 | -23 Thousand |
| Acquisitions | - | - | -2.91 Million | 39 Thousand | 5.46 Million | 15.17 Million |
| Investment purchases | -3.66 Million | -3 Million | -4.76 Million | -14.97 Million | -7.99 Million | -12.8 Million |
| Sales/Maturities of investments | 4.48 Million | 14.95 Million | 9.73 Million | 5.1 Million | 3.71 Million | 19.21 Million |
| Other Investing Activities | -9.37 Million | 127 Thousand | 2.91 Million | -4.53 Million | -4.28 Million | -15.17 Million |
| Financing Cash Flow | -4.38 Million | -7.26 Million | -6.99 Million | 4.54 Million | -10.06 Million | -8.73 Million |
| Debt repayment | -4.05 Million | -5.11 Million | -4.37 Million | -6.8 Million | -618 Thousand | -2.74 Million |
| Dividends payments | -979 Thousand | -1.47 Million | -1.47 Million | -1.37 Million | -1.96 Million | -4.07 Million |
| Common Stock Repurchased | -276 Thousand | -158 Thousand | -62 Thousand | - | -402 Thousand | -1.91 Million |
| Common Stock Issuance | 2 Million | -376 Thousand | -343 Thousand | - | -7.94 Million | 4.66 Million |
| Other Financing Activities | 925.99 Thousand | -143 Thousand | -740 Thousand | 12.72 Million | 862 Thousand | -5.35 Million |
| Accounts receivables | -2.53 Million | -1.38 Million | -940 Thousand | 387 Thousand | -1.07 Million | 303 Thousand |
| Accounts payables | -55 Thousand | 269 Thousand | -57 Thousand | -1.08 Million | 395 Thousand | -905 Thousand |
| Inventory | - | - | - | - | - | 994 Thousand |
| Other working capital | -7000.00 | -21 Thousand | 41 Thousand | -54 Thousand | 100 Thousand | -89 Thousand |
| Cash at beginning of period | 36.73 Million | 22.88 Million | 28.62 Million | 34.91 Million | 41.98 Million | 23.02 Million |
| Cash at end of period | 22.86 Million | 36.73 Million | 22.88 Million | 28.62 Million | 34.91 Million | 41.98 Million |
| Capital Expenditure | 581 Thousand | -1.1 Million | -2000.00 | -5000.00 | -4000.00 | -23 Thousand |
| Effect of forex changes on cash | - | -457 Thousand | -2.51 Million | 47 Thousand | -1 Million | - |
| Net cash flow / Change in cash | -13.86 Million | 13.85 Million | -5.74 Million | -6.28 Million | -7.06 Million | 18.95 Million |
| Free Cash Flow | -341 Thousand | 9.5 Million | -1.19 Million | 3.49 Million | 7.1 Million | 21.27 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.57 Million | 1.87 Million | -301 Thousand | -445 Thousand | 11.07 Million | 11.51 Million |
| Depreciation & Amortization | 401 Thousand | 201 Thousand | 200 Thousand | 200 Thousand | 410 Thousand | 210 Thousand |
| Deferred income taxes | - | - | - | 896 Thousand | -2.01 Million | - |
| Stock-based compensation | - | 125 Thousand | - | 84 Thousand | 84 Thousand | - |
| Change in working capital | -2.53 Million | -2.54 Million | - | -1.36 Million | -1.13 Million | - |
| Other non-cash items | 3.37 Million | -1.73 Million | 1.66 Million | -3.75 Million | 2.18 Million | 3.69 Million |
| Investing Cash Flow | -7.33 Million | 1.23 Million | -7.79 Million | 1 Million | 10.97 Million | 9.96 Million |
| Investments in PPE | - | 1.74 Million | - | -1.1 Million | -1.1 Million | - |
| Acquisitions | - | - | - | -1.00 | - | - |
| Investment purchases | -4.43 Million | -4.02 Million | -414 Thousand | -2.44 Million | -3 Million | -558 Thousand |
| Sales/Maturities of investments | 5.71 Million | 3.71 Million | 2 Million | 3.91 Million | 14.95 Million | 11.03 Million |
| Other Investing Activities | -9.37 Million | 1.23 Million | -9.37 Million | 642 Thousand | 127 Thousand | -515 Thousand |
| Financing Cash Flow | -6.38 Million | -5.2 Million | -1.17 Million | -5.03 Million | -7.26 Million | -2.23 Million |
| Debt repayment | -3.64 Million | -3.64 Million | -200 Thousand | -4.61 Million | -5.11 Million | -500 Thousand |
| Dividends payments | -979 Thousand | -489 Thousand | -490 Thousand | - | -1.47 Million | -1.47 Million |
| Common Stock Repurchased | -276 Thousand | -198 Thousand | -78 Thousand | -129 Thousand | -158 Thousand | -29 Thousand |
| Common Stock Issuance | - | - | - | - | -376 Thousand | -86 Thousand |
| Other Financing Activities | -1.07 Million | -4.52 Million | -406 Thousand | -4.9 Million | -143 Thousand | -143 Thousand |
| Accounts receivables | -2.53 Million | -2.53 Million | - | -1.38 Million | -1.38 Million | - |
| Accounts payables | -55 Thousand | - | - | - | 269 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 57 Thousand | -7000.00 | - | 11 Thousand | -21 Thousand | - |
| Cash at beginning of period | 36.73 Million | 28.92 Million | 36.73 Million | 45.61 Million | 22.88 Million | 22.88 Million |
| Cash at end of period | 22.86 Million | 22.86 Million | 28.92 Million | 36.73 Million | 36.73 Million | 45.61 Million |
| Capital Expenditure | - | 1.74 Million | - | -1.1 Million | -1.1 Million | - |
| Effect of forex changes on cash | - | - | - | -37.18 Million | -457 Thousand | 22.88 Million |
| Net cash flow / Change in cash | -13.86 Million | -6.05 Million | -7.8 Million | -8.88 Million | 13.85 Million | 22.73 Million |
| Free Cash Flow | -581 Thousand | -341 Thousand | 1.16 Million | -5.5 Million | 9.5 Million | 15 Million |
SEVENHILL
300502
6610
TCBIO
8213
GRANULES